Which has better earnings & valuation, IPI or CBUS?

Intrepid Potash has higher revenue and earnings than Cibus. Cibus is trading at a lower price-to-earnings ratio than Intrepid Potash, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Intrepid Potash $301.64M 1.64 $11.19M $1.98 18.62 Cibus $4.29M 33.30 -$127.08M -$1.97 N/A

Is IPI or CBUS more profitable?

Intrepid Potash has a net margin of 8.94% compared to Cibus' net margin of -2,366.33%. Intrepid Potash's return on equity of 4.74% beat Cibus' return on equity. Company Net Margins Return on Equity Return on Assets Intrepid Potash 8.94% 4.74% 3.73% Cibus -2,366.33% -200.87% -28.28%

Does the media prefer IPI or CBUS?

In the previous week, Intrepid Potash had 2 more articles in the media than Cibus. MarketBeat recorded 5 mentions for Intrepid Potash and 3 mentions for Cibus. Cibus' average media sentiment score of 0.62 beat Intrepid Potash's score of 0.56 indicating that Cibus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intrepid Potash 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cibus 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend AVD or CBUS?

Cibus has a consensus target price of $9.00, indicating a potential upside of 381.28%. Given Cibus' stronger consensus rating and higher possible upside, analysts clearly believe Cibus is more favorable than American Vanguard. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cibus 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, AVD or CBUS?

American Vanguard has higher revenue and earnings than Cibus. American Vanguard is trading at a lower price-to-earnings ratio than Cibus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Vanguard $515.11M 0.12 -$49.88M -$1.59 N/A Cibus $4.29M 33.30 -$127.08M -$1.97 N/A

Is AVD or CBUS more profitable?

American Vanguard has a net margin of -10.70% compared to Cibus' net margin of -2,366.33%. American Vanguard's return on equity of -8.83% beat Cibus' return on equity. Company Net Margins Return on Equity Return on Assets American Vanguard -10.70% -8.83% -2.78% Cibus -2,366.33% -200.87% -28.28%

Does the media prefer AVD or CBUS?

In the previous week, American Vanguard had 4 more articles in the media than Cibus. MarketBeat recorded 7 mentions for American Vanguard and 3 mentions for Cibus. Cibus' average media sentiment score of 0.62 beat American Vanguard's score of -0.40 indicating that Cibus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Vanguard 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Cibus 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is CBUS or BIOX more profitable?

Bioceres Crop Solutions has a net margin of -92.85% compared to Cibus' net margin of -2,366.33%. Bioceres Crop Solutions' return on equity of -33.97% beat Cibus' return on equity. Company Net Margins Return on Equity Return on Assets Cibus -2,366.33% -200.87% -28.28% Bioceres Crop Solutions -92.85% -33.97% -10.31%

Do analysts recommend SNES or CBUS?

Cibus has a consensus target price of $9.00, indicating a potential upside of 381.28%. Given Cibus' stronger consensus rating and higher possible upside, analysts clearly believe Cibus is more favorable than Senestech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Senestech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cibus 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is SNES or CBUS more profitable?

Senestech has a net margin of -294.73% compared to Cibus' net margin of -2,366.33%. Senestech's return on equity of -71.89% beat Cibus' return on equity. Company Net Margins Return on Equity Return on Assets Senestech -294.73% -71.89% -51.98% Cibus -2,366.33% -200.87% -28.28%

Does the media prefer SNES or CBUS?

In the previous week, Senestech had 8 more articles in the media than Cibus. MarketBeat recorded 11 mentions for Senestech and 3 mentions for Cibus. Senestech's average media sentiment score of 0.83 beat Cibus' score of 0.62 indicating that Senestech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Senestech 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cibus 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, CTVA or CBUS?

Corteva has higher revenue and earnings than Cibus. Cibus is trading at a lower price-to-earnings ratio than Corteva, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Corteva $17.81B 2.83 $1.09B $1.51 49.97 Cibus $4.29M 33.30 -$127.08M -$1.97 N/A

Is CTVA or CBUS more profitable?

Corteva has a net margin of 5.66% compared to Cibus' net margin of -2,366.33%. Corteva's return on equity of 10.18% beat Cibus' return on equity. Company Net Margins Return on Equity Return on Assets Corteva 5.66% 10.18% 6.00% Cibus -2,366.33% -200.87% -28.28%

Does the media prefer CTVA or CBUS?

In the previous week, Corteva had 3 more articles in the media than Cibus. MarketBeat recorded 6 mentions for Corteva and 3 mentions for Cibus. Corteva's average media sentiment score of 0.72 beat Cibus' score of 0.62 indicating that Corteva is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Corteva 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cibus 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cibus (CBUS) Competitors

$1.90 +0.01 (+0.26%)

As of 10:44 AM Eastern

Compare

CBUS vs. IPI, AVD, BIOX, SNES, and CTVA

Should you buy Cibus stock or one of its competitors? Cibus's main competitors and comparable companies include Intrepid Potash (IPI), American Vanguard (AVD), Bioceres Crop Solutions (BIOX), Senestech (SNES), and Corteva (CTVA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "fertilizers & agricultural chemicals" industry.

How does Cibus compare to Intrepid Potash?

Intrepid Potash (NYSE:IPI) and Cibus (NASDAQ:CBUS) are both small-cap materials companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

56.1% of Intrepid Potash shares are owned by institutional investors. Comparatively, 33.8% of Cibus shares are owned by institutional investors. 2.3% of Intrepid Potash shares are owned by company insiders. Comparatively, 29.9% of Cibus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Intrepid Potash had 2 more articles in the media than Cibus. MarketBeat recorded 5 mentions for Intrepid Potash and 3 mentions for Cibus. Cibus' average media sentiment score of 0.62 beat Intrepid Potash's score of 0.56 indicating that Cibus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intrepid Potash	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cibus	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Intrepid Potash currently has a consensus target price of $26.00, indicating a potential downside of 29.47%. Cibus has a consensus target price of $9.00, indicating a potential upside of 381.28%. Given Cibus' higher possible upside, analysts clearly believe Cibus is more favorable than Intrepid Potash.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intrepid Potash	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
Cibus	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Intrepid Potash has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market. Comparatively, Cibus has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market.

Intrepid Potash has a net margin of 8.94% compared to Cibus' net margin of -2,366.33%. Intrepid Potash's return on equity of 4.74% beat Cibus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intrepid Potash	8.94%	4.74%	3.73%
Cibus	-2,366.33%	-200.87%	-28.28%

Intrepid Potash has higher revenue and earnings than Cibus. Cibus is trading at a lower price-to-earnings ratio than Intrepid Potash, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intrepid Potash	$301.64M	1.64	$11.19M	$1.98	18.62
Cibus	$4.29M	33.30	-$127.08M	-$1.97	N/A

Summary

Intrepid Potash beats Cibus on 11 of the 17 factors compared between the two stocks.

How does Cibus compare to American Vanguard?

American Vanguard (NYSE:AVD) and Cibus (NASDAQ:CBUS) are both small-cap materials companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

American Vanguard has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market. Comparatively, Cibus has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market.

American Vanguard has a net margin of -10.70% compared to Cibus' net margin of -2,366.33%. American Vanguard's return on equity of -8.83% beat Cibus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Vanguard	-10.70%	-8.83%	-2.78%
Cibus	-2,366.33%	-200.87%	-28.28%

American Vanguard has higher revenue and earnings than Cibus. American Vanguard is trading at a lower price-to-earnings ratio than Cibus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Vanguard	$515.11M	0.12	-$49.88M	-$1.59	N/A
Cibus	$4.29M	33.30	-$127.08M	-$1.97	N/A

Cibus has a consensus target price of $9.00, indicating a potential upside of 381.28%. Given Cibus' stronger consensus rating and higher possible upside, analysts clearly believe Cibus is more favorable than American Vanguard.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cibus	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

79.0% of American Vanguard shares are owned by institutional investors. Comparatively, 33.8% of Cibus shares are owned by institutional investors. 5.6% of American Vanguard shares are owned by company insiders. Comparatively, 29.9% of Cibus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, American Vanguard had 4 more articles in the media than Cibus. MarketBeat recorded 7 mentions for American Vanguard and 3 mentions for Cibus. Cibus' average media sentiment score of 0.62 beat American Vanguard's score of -0.40 indicating that Cibus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Vanguard	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Cibus	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

American Vanguard and Cibus tied by winning 8 of the 16 factors compared between the two stocks.

How does Cibus compare to Bioceres Crop Solutions?

Cibus (NASDAQ:CBUS) and Bioceres Crop Solutions (NASDAQ:BIOX) are both small-cap materials companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

33.8% of Cibus shares are held by institutional investors. Comparatively, 17.7% of Bioceres Crop Solutions shares are held by institutional investors. 29.9% of Cibus shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Cibus currently has a consensus target price of $9.00, indicating a potential upside of 381.28%. Bioceres Crop Solutions has a consensus target price of $4.00, indicating a potential upside of 975.27%. Given Bioceres Crop Solutions' higher probable upside, analysts clearly believe Bioceres Crop Solutions is more favorable than Cibus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cibus	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bioceres Crop Solutions	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Cibus had 2 more articles in the media than Bioceres Crop Solutions. MarketBeat recorded 3 mentions for Cibus and 1 mentions for Bioceres Crop Solutions. Bioceres Crop Solutions' average media sentiment score of 1.88 beat Cibus' score of 0.62 indicating that Bioceres Crop Solutions is being referred to more favorably in the news media.

Company	Overall Sentiment
Cibus	Positive
Bioceres Crop Solutions	Very Positive

Cibus has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market. Comparatively, Bioceres Crop Solutions has a beta of 0.41, meaning that its share price is 59% less volatile than the broader market.

Bioceres Crop Solutions has higher revenue and earnings than Cibus. Cibus is trading at a lower price-to-earnings ratio than Bioceres Crop Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cibus	$4.29M	33.30	-$127.08M	-$1.97	N/A
Bioceres Crop Solutions	$333.30M	0.07	-$55.42M	-$3.86	N/A

Bioceres Crop Solutions has a net margin of -92.85% compared to Cibus' net margin of -2,366.33%. Bioceres Crop Solutions' return on equity of -33.97% beat Cibus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cibus	-2,366.33%	-200.87%	-28.28%
Bioceres Crop Solutions	-92.85%	-33.97%	-10.31%

Summary

Bioceres Crop Solutions beats Cibus on 8 of the 14 factors compared between the two stocks.

How does Cibus compare to Senestech?

Senestech (NASDAQ:SNES) and Cibus (NASDAQ:CBUS) are both small-cap materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Senestech has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market. Comparatively, Cibus has a beta of 1.61, suggesting that its stock price is 61% more volatile than the broader market.

Senestech has higher earnings, but lower revenue than Cibus. Cibus is trading at a lower price-to-earnings ratio than Senestech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senestech	$2.37M	2.84	-$6.38M	-$1.37	N/A
Cibus	$4.29M	33.30	-$127.08M	-$1.97	N/A

Senestech has a net margin of -294.73% compared to Cibus' net margin of -2,366.33%. Senestech's return on equity of -71.89% beat Cibus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Senestech	-294.73%	-71.89%	-51.98%
Cibus	-2,366.33%	-200.87%	-28.28%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senestech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cibus	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

5.2% of Senestech shares are owned by institutional investors. Comparatively, 33.8% of Cibus shares are owned by institutional investors. 2.2% of Senestech shares are owned by company insiders. Comparatively, 29.9% of Cibus shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Senestech had 8 more articles in the media than Cibus. MarketBeat recorded 11 mentions for Senestech and 3 mentions for Cibus. Senestech's average media sentiment score of 0.83 beat Cibus' score of 0.62 indicating that Senestech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Senestech	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cibus	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cibus beats Senestech on 9 of the 16 factors compared between the two stocks.

How does Cibus compare to Corteva?

Corteva (NYSE:CTVA) and Cibus (NASDAQ:CBUS) are both materials companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.

81.5% of Corteva shares are held by institutional investors. Comparatively, 33.8% of Cibus shares are held by institutional investors. 0.2% of Corteva shares are held by company insiders. Comparatively, 29.9% of Cibus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Corteva has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market. Comparatively, Cibus has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market.

Corteva has a net margin of 5.66% compared to Cibus' net margin of -2,366.33%. Corteva's return on equity of 10.18% beat Cibus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Corteva	5.66%	10.18%	6.00%
Cibus	-2,366.33%	-200.87%	-28.28%

In the previous week, Corteva had 3 more articles in the media than Cibus. MarketBeat recorded 6 mentions for Corteva and 3 mentions for Cibus. Corteva's average media sentiment score of 0.72 beat Cibus' score of 0.62 indicating that Corteva is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Corteva	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cibus	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Corteva presently has a consensus price target of $91.70, indicating a potential upside of 21.52%. Cibus has a consensus price target of $9.00, indicating a potential upside of 381.28%. Given Cibus' higher probable upside, analysts clearly believe Cibus is more favorable than Corteva.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Corteva	0 Sell rating(s)	8 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.70
Cibus	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Corteva has higher revenue and earnings than Cibus. Cibus is trading at a lower price-to-earnings ratio than Corteva, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Corteva	$17.81B	2.83	$1.09B	$1.51	49.97
Cibus	$4.29M	33.30	-$127.08M	-$1.97	N/A

Summary

Corteva beats Cibus on 13 of the 17 factors compared between the two stocks.

Get Cibus News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CBUS vs. The Competition

Export

Metric	Cibus	Chemicals Industry	Materials Sector	NASDAQ Exchange
Market Cap	$143.12M	$11.39B	$4.92B	$12.93B
Dividend Yield	N/A	2.86%	4.71%	10.34%
P/E Ratio	-0.95	20.88	21.59	25.24
Price / Sales	33.30	52.43	5,193.67	74.43
Price / Cash	N/A	15.51	27.12	50.42
Price / Book	4.68	3.90	8.90	6.21
Net Income	-$127.08M	$223.51M	$154.60M	$347.05M
7 Day Performance	-3.11%	1.10%	3.87%	1.43%
1 Month Performance	-7.43%	3.39%	6.26%	-0.53%
1 Year Performance	36.50%	21.64%	44.37%	20.94%

Cibus Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CBUS Cibus	1.2697 of 5 stars	$1.91 +0.3%	$9.00 +372.4%	+35.7%	$145.11M	$4.29M	N/A	48	Upcoming Earnings
IPI Intrepid Potash	2.0764 of 5 stars	$35.06 +0.4%	$26.00 -25.8%	+28.5%	$469.58M	$298.33M	17.66	440	Analyst Upgrade
AVD American Vanguard	1.6567 of 5 stars	$2.49 -3.0%	N/A	-52.0%	$71.09M	$522.88M	N/A	800	News Coverage Earnings Report Gap Up
BIOX Bioceres Crop Solutions	2.7894 of 5 stars	$0.36 -0.8%	$4.00 +1,020.4%	-88.4%	$22.57M	$333.30M	N/A	500	Positive News
SNES Senestech	1.5464 of 5 stars	$1.30 +2.0%	N/A	-71.2%	$6.86M	$2.22M	N/A	30	Earnings Report Short Interest Increase Analyst Revision Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CBUS) was last updated on 8/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cibus (CBUS) Competitors

CBUS vs. IPI, AVD, BIOX, SNES, and CTVA

How does Cibus compare to Intrepid Potash?

Summary

How does Cibus compare to American Vanguard?

Summary

How does Cibus compare to Bioceres Crop Solutions?

Summary

How does Cibus compare to Senestech?

Summary

How does Cibus compare to Corteva?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CBUS vs. The Competition

Cibus Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cibus (CBUS) Competitors

CBUS vs. IPI, AVD, BIOX, SNES, and CTVA

How does Cibus compare to Intrepid Potash?

Do institutionals & insiders believe in IPI or CBUS?

Does the media prefer IPI or CBUS?

Do analysts recommend IPI or CBUS?

Which has more volatility & risk, IPI or CBUS?

Is IPI or CBUS more profitable?

Which has better earnings & valuation, IPI or CBUS?

Summary

How does Cibus compare to American Vanguard?

Which has more volatility & risk, AVD or CBUS?

Is AVD or CBUS more profitable?

Which has better earnings & valuation, AVD or CBUS?

Do analysts recommend AVD or CBUS?

Do institutionals & insiders believe in AVD or CBUS?

Does the media prefer AVD or CBUS?

Summary

How does Cibus compare to Bioceres Crop Solutions?

Do insiders and institutionals believe in CBUS or BIOX?

Do analysts prefer CBUS or BIOX?

Does the media refer more to CBUS or BIOX?

Which has more risk and volatility, CBUS or BIOX?

Which has stronger earnings & valuation, CBUS or BIOX?

Is CBUS or BIOX more profitable?

Summary

How does Cibus compare to Senestech?

Which has more volatility and risk, SNES or CBUS?

Which has preferable valuation & earnings, SNES or CBUS?

Is SNES or CBUS more profitable?

Do analysts recommend SNES or CBUS?

Do institutionals and insiders have more ownership in SNES or CBUS?

Does the media prefer SNES or CBUS?

Summary

How does Cibus compare to Corteva?

Do insiders and institutionals have more ownership in CTVA or CBUS?

Which has more risk and volatility, CTVA or CBUS?

Is CTVA or CBUS more profitable?

Does the media prefer CTVA or CBUS?

Do analysts rate CTVA or CBUS?

Which has stronger earnings & valuation, CTVA or CBUS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CBUS vs. The Competition

Cibus Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools